Who are we?

Pharmaseed is Israel’s largest GLP-certified pre-clinical and early clinical CRO specializing in translational and regenerative studies.

Pharmaseed is equipped for the execution of NCE studies, biologics and medical-devices as well as conducting and following through from the development stages until first-in-man trials. These studies include safety and efficacy evaluation in various animal models in addition to complementary in-vitro/ex-vivo models as well as clinical trial Services.

Pharmaseed’s expertise in preclinical studies lies mostly in the following areas:
Cardiovascular, Immuno-Oncology, Stem cell and Cellular Therapeutics, Microbiome research, Infectious Diseases, and CNS. 

Founded in 2003, Pharmaseed is a GLP-certified contract research organization (CRO) providing pre-clinical, early clinical and consulting services for medical device, biotechnology and pharmaceutical companies. Pharmaseed also provides pre-formulation services for small and medium-size start-up companies as well as companies in the idea and feasibility stages.

Pharmaseed’s experienced team forms an efficient organization whose global reach includes a network of sponsors from the U.S., Europe, Canada and Israel. This network has enabled Pharmaseed to establish JV programs with pharmaceutical companies and academia as well as a top-tier S.A.B./K.O.L. panel from multinational bio-pharma companies.

All our services are priced at a competitive rate in comparison to European and U.S.- based companies.

Why work with us?

Safety & ADME

Toxicity studies investigate the safety profile of a candidate compound, as well as providing important information about the absorption, distribution, metabolism, and excretion (ADME) of the compound in the body. A candidate compound must be assessed in different kinds of non-clinical toxicity studies before it can be administered to the first human volunteer. Toxicology studies can be either single-dose or repeated-dose studies.
Whether your compound is an original small molecule or bioequivalent generic, cell therapy, injectable large molecule or biosimilar – our experts are true specialists.

Our services support an array of therapeutic disciplines

Cannabis based therapy

Microbiome

Pharmaceuticals

Medical devices

Biological therapy

Nutraceuticals

Cell & Gene based Therapy

Our services utilize various animal species

Yeast

C-elegance

Drosophila

Zebrafish

Rat-mice

Rabbit

Pig

Human

Yeast

C-elegans

Drosophila

Zebrafish

Rat-mice

Rabbit

Pig

Human

REGULATORY SERVICES

ADME SERVICES

2 monts~
Average Time to Study Inittiation In Vivo
80%~
Returning Clients
150~
Average Studies
Per Year
50%+
PhD+ Level
Personnel

Get in touch